Anavex Life Sciences Corp (AVXL)

[bas2020]

Below is the most recent patent application update by Anavex on June 9. I cannot tell if this is for 2-73 or 3-71.

http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PG01&s1=Anavex&OS=Anavex&RS=Anavex


United States Patent Application 20160158209
Kind Code A1
Godek; Dennis Michael ; et al. June 9, 2016

Compounds for Treatment of Alzheimer's Disease


Abstract

The invention is directed to the use of a compound of formula I, as defined herein, to a pharmaceutically acceptable salt thereof; to a pharmaceutical composition containing a compound of formula I, and to a combination of a compound of formula I with a pharmacologically effective cholinesterase inhibitor to treat a mammal, including a human, for a disorder or condition selected from the list including Alzheimer's disease, Huntington's disease, Parkinson's disease, non-Alzheimer's dementias and ALS.


Inventors: Godek; Dennis Michael; (Glastonbury, CT) ; Howard; Harry Ralph; (Bristol, CT)


Applicant:


Name
Godek; Dennis Michael
Howard; Harry Ralph

City
Glastonbury

State
Bristol

Country

Type
CT
CT
US
US

Assignee: MediSynergics, LLC
Newington
CT

Family ID: 56093272
Appl. No.: 14/854928
Filed: September 15, 2015

Related U.S. Patent Documents

Application Number

Filing Date

Patent Number

14523278 Oct 24, 2014 9169237
14854928
61899181 Nov 2, 2013